CIAN
AVNS icon

Capstone Investment Advisors (Netherlands)’s Avanos Medical AVNS Stock Holding History

Capstone Investment Advisors (Netherlands)’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$230K Sell
5,848
-1,289
-18% -$48.7K 0.8% 62
2017
Q1 		$272K Sell
7,137
-1,260
-15% -$49.1K 0.77% 64
2016
Q4 		$311K Buy
+8,397
New +$300K 0.53% 93

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Capstone Investment Advisors (Netherlands)'s AVNS Position: Q2 2017 in Review

Capstone Investment Advisors (Netherlands) reduced its Avanos Medical (AVNS) stake by 18% in Q2 2017, selling an estimated $48.7K and leaving 5,848 shares worth $230K. The position accounts for 0.8% of the portfolio, ranked #62.

Capstone Investment Advisors (Netherlands) first reported a position in AVNS in Q4 2016 and has held it in 3 quarters since. The position peaked at $311K in Q4 2016. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Capstone Investment Advisors (Netherlands) held 5,848 shares of Avanos Medical worth $230K as of Q2 2017.
  • Capstone Investment Advisors (Netherlands) sold 1,289 Avanos Medical shares in Q2 2017, an estimated $48.7K.
  • Avanos Medical made up 0.8% of Capstone Investment Advisors (Netherlands)'s portfolio in Q2 2017, its #62 holding.
  • Capstone Investment Advisors (Netherlands) first reported a position in Avanos Medical in Q4 2016 and has held it in 3 quarters since.
  • Capstone Investment Advisors (Netherlands)'s Avanos Medical position peaked at $311K in Q4 2016.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Capstone Investment Advisors (Netherlands)'s 13F filing for Q2 2017, filed 14 Aug 2017.